StockTipsArenaBeta

BUY Mankind Pharma Limited — Mehul Kothari, Anand Rathi

BUYMankind Pharma Limited
Mankind Pharma share price target & all analyst calls

byMehul Kothari, Anand RathiHorizon: NA (inferred Swing (≤2wk))9 Nov 2026via Zee Business (Live)

Entry₹2,673Inferred
Target₹3,000
Total upside +12.23%
Stop loss₹2,550-4.60% risk
CMP₹2,6401d ago
Active-1.23%+13.64%upside left 8d left
Follow Mehul Kothari for new calls(22% target hit, 121 closed calls)Get alertsWatch MANKIND for new buy/sell callsGet alertsSee 1 other Swing call on MANKINDSee 281 other Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 15 Nov, 3:41 am IST
11 supporting2 neutral1 opposing
Supports the BUY call (11)

MACD above its signal line — bullish momentum

Technicals · macd·14 Nov · today

2 advisors have active short-term BUY calls on this stock, all issued in the last 14 days

Advisor consensus · adjacent horizon·11 Nov · 3d ago

1 other SEBI-registered advisor has an active swing BUY call on this stock, issued in the last 14 days

Advisor consensus · same horizon·11 Nov · 3d ago

Mankind Pharma shares jump 8% as Q2 profit rises 38% to Rs 716 crore

NewsEt-Markets·27 Oct · 3w ago

(opens in new tab)

Dr Reddy's stock could rise 10-15% if a major biosimilar gets approved in December: Systematix

NewsCnbc-Tv18·27 Oct · 3w ago

(opens in new tab)
Neutral / worth noting (2)

Mankind Pharma Q2 Review: Export Momentum Continues; Systematix Maintains 'Hold'; Check Target Price

NewsNdtv-Profit·27 Oct · 3w ago

(opens in new tab)

Mankind Pharma Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.

NSE · Outcome of Board Meeting·26 Oct · 3w ago

(opens in new tab)
Weighs against the BUY call (1)

RSI at 81 — overbought territory

Technicals · rsi·14 Nov · today

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Mankind Pharma

All analyst calls on Mankind Pharma

More from Mehul Kothari, Anand Rathi

Every call and its outcome